Guanhao Biotech(SZ:300238)2024-03-15 09:53Group 1: Company Overview - Guanhao Biological Technology Co., Ltd. is focused on regenerative medicine and aims to become a leading provider of products, technology, and services in this field [1] - The company has been recognized as a first-in-class drug by the Ministry of Science and Technology and is part of major national projects for new drug development [2] Group 2: Product Information - The product "Bimoderm Cream" (commercial name: Xinbik) has a medical insurance payment standard of 138 RMB for a 10g tube [1] - Bimoderm is classified as a Class 1 new drug and is effective for inflammatory and autoimmune diseases [1] Group 3: Marketing Strategy - The company employs a dual-driven marketing model combining online and offline strategies, as well as self-operated and agency sales [2] - There is a continuous effort to enhance market development across the country [2] Group 4: Future Development and Investor Relations - The company plans to strengthen R&D project management and resource allocation to drive high-quality development [2] - It emphasizes transparent communication with investors through various channels, including performance briefings and dedicated investor interaction platforms [2]